Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Behavioral and imaging study of Tian Xin Tai Xueshuanxinmaining in stroke
ChiCTR-TRC-12003074Phase 4Completed
- Sponsor
- Beijing Hospital
- Start
- Jan 2012
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Xueshuanxinmaining tablets in ischemic stroke and brain infarction (2 arms), sponsored by Beijing Hospital. Primary endpoint: Stroke Specific Quality of Life Scale. Started Jan 2012; status: completed.
02
Drugs
Xueshuanxinmaining tablets
03
Conditions
ischemic strokebrain infarction
Beyond the preview
Go deeper on ChiCTR-TRC-12003074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12003074.